Viking Therapeutics Inc

NASDAQ:VKTX   3:58:35 PM EDT
6.07
-0.10 (-1.62%)
Earnings Announcements

Viking Therapeutics Reports Q1 Loss Per Share Of $0.19

Published: 04/28/2021 22:12 GMT
Viking Therapeutics Inc (VKTX) - Viking Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update.
Q1 Loss per Share $0.19.
Quarter-end Cash Approximately $242 Million; Provides Ample Runway to Achieve Key Clinical Milestones.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.